Custom Search Insider Trading Activity Insider Trading Activity
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Custom Search Insider Trading Activity
Updated Mar 5, 2024
Ticker
|
Company Name
|
Qty.
|
Price
|
Size ($)
|
Filing Date
|
Type
|
Δ Own
|
Own
|
Insider Names
|
Title
|
Trade Dates
|
Is Scheduled
| |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Bridgebio Pharma, Inc.
| -2.50K |
$34.00 | -$85,000.00 | -27.78% | 6.5K |
Mar 1
| |||||||
Bridgebio Pharma, Inc.
| -2.00K |
$40.00 | -$80,000.00 | -18.18% | 9K |
Dec 18
|
Scheduled
| ||||||
Bridgebio Pharma, Inc.
| -2.50K |
$29.40 | -$73,500.00 | -18.52% | 11K |
Dec 1
|
Scheduled
| ||||||
Bridgebio Pharma, Inc.
| -2.50K |
$30.00 | -$75,000.00 | -15.63% | 13.5K |
Sep 5
| |||||||
Bridgebio Pharma, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 21
| |||||||
Talis Biomedical Corp
|
0
|
—
|
—
|
—
|
0
|
Jun 9
| |||||||
Invitae Corp
| 70.42K |
—
|
—
| +77.56% | 161.22K |
Apr 27
| |||||||
Invitae Corp
| 53.8K |
—
|
—
| +145.41% | 90.8K |
Jul 16
| |||||||
Invitae Corp
|
0
|
—
|
—
|
—
|
0
| ||||||||
Bridgebio Pharma, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 22
| |||||||
Talis Biomedical Corp
|
0
|
—
|
—
|
—
|
0
|
Jun 10
| |||||||
Bridgebio Pharma, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 17
| |||||||
Talis Biomedical Corp
| 20K |
$10.13 | $202,650.00 |
∞
| 20K |
May 14 - May 17
| |||||||
Talis Biomedical Corp
| 1.7M |
$16.00 | $5,000,000.00 |
∞
| 1.7M |
Feb 17
| |||||||
Bridgebio Pharma, Inc.
| 16K |
$62.50 | $1,000,000.00 | +320.00% | 21K |
Feb 17
| |||||||
Talis Biomedical Corp
|
0
|
—
|
—
|
—
|
0
| ||||||||
Bridgebio Pharma, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 23
| |||||||
Bridgebio Pharma, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Invitae Corp
| -40.00K |
$24.59 | -$983,404.72 | -1.15% | 3.45M |
Aug 26
|
Scheduled
| ||||||
Invitae Corp
| -30.00K |
$17.60 | -$528,027.00 | -0.85% | 3.49M |
May 28
|
Scheduled
| ||||||
Invitae Corp
|
0
|
—
|
—
|
—
|
0
|
May 2
| |||||||
Invitae Corp
| -30.00K |
$19.10 | -$572,997.30 | -0.84% | 3.52M |
Feb 25
|
Scheduled
| ||||||
Invitae Corp
|
0
|
—
|
—
|
—
|
0
|
Jun 22
| |||||||
Invitae Corp
| 44.44K |
$4.50 | $199,998.00 | +1.27% | 3.55M |
Apr 2
| |||||||
Invitae Corp
|
0
|
—
|
—
|
—
|
0
|
May 2
| |||||||
Invitae Corp
| 66.67K |
$6.00 | $399,996.00 | +1.94% | 3.51M |
Nov 22
| |||||||
Invitae Corp
| 3.44M |
—
|
—
|
∞
| 3.44M |
Feb 18
| |||||||
Invitae Corp
|
0
|
—
|
—
|
—
|
0
| ||||||||
Genomic Health Inc
| -30.00K |
$35.39 | -$1,061,670.68 | -2.47% | 1.19M | +1 |
Jul 10 - Jul 11
|
Scheduled
| |||||
Genomic Health Inc
| -30.00K |
$33.54 | -$1,006,216.26 | -2.41% | 1.22M | +1 |
Jun 11 - Jun 12
|
Scheduled
| |||||
Genomic Health Inc
| -30.00K |
$30.22 | -$906,723.46 | -2.35% | 1.25M | +1 |
May 10 - May 11
|
Scheduled
| |||||
Genomic Health Inc
| -20.00K |
$28.59 | -$571,871.29 | -1.54% | 1.28M | +1 |
Apr 10 - Apr 11
|
Scheduled
| |||||
Genomic Health Inc
| -30.00K |
$31.05 | -$931,444.50 | -2.26% | 1.3M | +1 |
Mar 12 - Mar 13
|
Scheduled
| |||||
Genomic Health Inc
| -629.00 |
$28.97 | -$18,222.13 | -0.05% | 1.33M |
Feb 15
| |||||||
Genomic Health Inc
| -20.00K |
$26.18 | -$523,524.00 | -1.49% | 1.33M |
Feb 9 - Feb 10
|
Scheduled
| ||||||
Genomic Health Inc
| -20.00K |
$26.18 | -$523,524.00 | -1.49% | 1.33M |
Feb 9 - Feb 10
|
Scheduled
| ||||||
Genomic Health Inc
| 4.6K |
—
|
—
| +0.34% | 1.35M |
Feb 5
| |||||||
Genomic Health Inc
| 4.6K |
—
|
—
| +0.34% | 1.35M |
Feb 5
| |||||||
Genomic Health Inc
| -20.00K |
$27.46 | -$549,141.56 | -1.47% | 1.34M |
Jan 10 - Jan 11
|
Scheduled
| ||||||
Genomic Health Inc
| -20.00K |
$27.29 | -$545,730.20 | -1.45% | 1.36M |
Dec 12 - Dec 13
|
Scheduled
| ||||||
It looks like there's no data for these filter options. Maybe you'll be interested in these options instead. |
Want to view more results?
Unlock the hidden results with your Benzinga Account now. No purchase required.